A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

Clinical trial NCT07779460 · RECRUITING

Trial details

NCT number: NCT07779460
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2026-04-08
Primary completion: 2026-12-31
Enrollment: 7466

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.